Hashimoto’s encephalopathy

Czech version

Authors: H. Vondrová
Authors‘ workplace: Neurologická klinika IPVZ a Fakultní Thomayerovy nemocnice, Praha, přednosta doc. MUDr. Otakar Keller, CSc.
Published in: Vnitř Lék 2006; 52(10): 954-956
Category: Review

Overview

Hashimoto’s encephalopathy (HE) is not an often complication of autoimmune thyroiditis, usually at the time the patient is already euthyroid i.e. with normal TSH-value but positive antibodies to thyroid hormones. Signs and symptoms are acute or sub-acute, such as cerebrovascular accident, epileptic seizures generalised, myoclonic or partial, cognitive function disorder with dementia and psychical disorders. Pathological nálezy, even non-specifical, can be found in cerebrospinal fluid, by electroencefalography (EEG) or by brain scan with magnetic resonance (MR). Pathogenesy of the disease is unclear; however, corticoid treatment is usually succesful. Therefore, HE should be taken into consideration after elimination of all other causes of encephalopathy, with thyroiditis in family history in particular.

Key words:
cognitive disorders – epileptic seizures – antibodies to thyroid hormones – corticoid treatment

Sources

1. Castillo P, Woodruff B, Caselli R et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006; 63: 197-202.

2. Perrot X, Giraud P, Biacabe AG et al. Hashimoto´s encephalopathy: an anatomoclinical observation (in French). Rev Neurol (Paris) 2002; 158: 461-466.

3. Jacobs A, Root J, VanGorp W. Isolated global amnesia associated with autoimmune thyroid disease. Neurology 2006; 66: 605-606.

4. Ghika-Schmid F, Ghika J, Regli F et al. Hashimoto´s myoclonic encephalopathy: an underdiagnosed treatable condition? Mov Disord 1996; 11: 555-562.

5. Arain A, Abou-Khalil B, Moses H. Hashimoto´s encefalopathy: documentation of mesial temporal seizure origin by ictal EEG. Seizure 2001; 10: 438-441.

6. Peschen-Rosin R, Schabet M, Dichgans J. Manifestation of Hashimoto´s encephalopathy years before onset of thyroid disease. Eur Neurol 1999; 41: 79-84.

7. Canton A, de Fabregas O, Tintore M et al. Encehalopathy associated to autoimmune thyroid disease: more appropriate term for an underestimated condition? J Neurol Sci 2000; 176: 65-69.

8. Ferracci F, Bertiato G, Moretto G. Hashimoto encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci 2004; 217: 165-168.

9. Sawka AM, Fatourechi V, Boeve BF et al. Rarity of encephalopathy associated with autoimmune thyroiditis. a case series from Mayo Clinic from 1950 to 1996. Thyroid 2002; 12: 393-398.

10. Ferracci F, Moretto G, Candeago R et al. Antithyroid antibodies in the CSF: Their role in the pathogenesis of Hashimoto´s encephalopathy. Neurology 2003; 60: 712-714.

11. Chen HC, Marsharani U. Hashimoto´s encephalopathy. South Med J 2000; 93: 504-506.

12. Schauble B, Castillo PR, Boeve BF et al. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 2003; 114: 32-37.

13. Seo SW, Lee BI, Lee JD et al. Thyrotoxic autoimmune encephalopathy: a repeat positron emission tomography study. J Neurol Neurosurg Psych 2003; 74: 504-506.

14. Hussain NS, Rumbaugh J, Kerr D et al. Effects of prednisone and plasma exchange on cognitive impairment in Hashimoto encephalopathy. Neurology 2005; 64: 165-166.